Sumitomo Chemical Company, Limited ( SOMMY ) Q4 2025 Earnings Call May 14, 2026 3:30 AM EDT Company Participants Toshihiro Yamauchi Nobuaki Mito - President, CEO, Head of Advanced Medical Solutions Sector & Representative Director Conference Call Participants Takato Watabe - Morgan Stanley, Research Division Mikiya Yamada - Mizuho Securities Co., Ltd., Research Division Go Miyamoto - SMBC Nikko Securities Inc., Research Division Shigeki Okazaki - Nomura Securities Co. Ltd., Research Division Shunta Omura - UBS Investment Bank, Research Division Presentation Toshihiro Yamauchi My name is Yamauchi, and I will be serving as today's moderator. We appreciate you taking the time out of your busy schedules to attend our Investors Meeting for FY 2025 financial results, management priorities and business strategies. Today's session will begin with a presentation by our President Mito, followed by a Q&A session, and we are scheduled to conclude at 5:45 p.m. With that, Mr. Mito, the floor is yours.…